AGNPF Projected Dividend Yield
Cl A (New)/Algernon Pharmaceuticals Inc ( OTCBB : AGNPF )Algernon Pharmaceuticals is a drug re-purposing company that investigates safe, already approved drugs for multiple new disease applications, moving them efficiently and safely into new human trails. Co. is a clinical stage pharmaceutical development company focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis, chronic kidney disease, inflammatory bowel disease, idiopathic pulmonary fibrosis and chronic cough. Co. operates in two reportable operating segments being the development of repurposed therapeutic drugs in Canada and the facilitation of Co.'s lead drug candidates into off-label phase II clinical trials (humans) in Australia. 20 YEAR PERFORMANCE RESULTS |
AGNPF Dividend History Detail AGNPF Dividend News AGNPF Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |